Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
Strahlentherapie und Onkologie
Published in: Strahlentherapie und Onkologie 10/2014

01-10-2014 | Literatur kommentiert

„Bananenkurve“ im Überleben nach alleiniger Strahlentherapie fortgeschrittener Kopf-Hals-Karzinome

Author: Hartmut T. Klages

Published in: Strahlentherapie und Onkologie | Issue 10/2014

Login to get access

Auszug

Beitler JJ, Zhang Q, Fu KK et al (2014) Final results of local-regional control and late toxicity of RTOG 9003: a randomized trial of altered fractionation radiation for locally advanced head and neck cancer. Int J Radiat Oncol Biol Phys 89(1):13–20 …
Literature
1.
Baujat B, Bourhis J, Blanchard P, MARCH Collaborative Group et al (2010) Hyperfractionated or accelerated radiotherapy for head and neck cancer. Cochrane Database Syst Rev CD002026. doi:10.1002/14651858.CD002026
2.
Baumann M, Klages HT (2001) Vergleich verschiedener Fraktionierungsschemata bei der alleinigen kurativen Strahlentherapie lokal fortgeschrittener Kopf-Hals-Tumoren. Strahlenther Onkol 177:162–165PubMed
3.
Beck-Bornholdt HP, Dubben HH (2000) Multiple Signifikanztests und ihre Bedeutung bei der Beurteilung von Resultaten. Strahlenther Onkol 176:344–349PubMedCrossRef
4.
Beitler JJ, Zhang Q, Fu KK et al (2014) Final results of local-regional control and late toxicity of RTOG 9003: a randomized trial of altered fractionation radiation for locally advanced head and neck cancer. Int J Radiat Oncol Biol Phys 89:13–20PubMedCrossRef
5.
Bourhis J, Sire C, Graff P, Grégoire V et al (2012) Concomitant chemoradiotherapy versus acceleration of radiotherapy with or without concomitant chemotherapy in locally advanced head and neck carcinoma (GORTEC 99-02): an open-label phase 3 randomised trial. Lancet Oncol 13:145–153PubMedCrossRef
6.
Budach W, Hehr T, Budach V et al (2006) A meta-analysis of hyperfractionated and accelerated radiotherapy and combined chemotherapy and radiotherapy regimens in unresected locally advanced squamous cell carcinoma of the head and neck. BMC Cancer 6:28PubMedCrossRefPubMedCentral
7.
Forastiere AA, Goepfert H, Maor M et al (2003) Concurrent chemotherapy and radiotherapy for organ preservation in advanced laryngeal cancer. N Engl J Med 349:2091–2098PubMedCrossRef
8.
Fu KK, Pajak TF, Trotti A et al (2000) A Radiation Therapy Oncology Group (RTOG) phase III randomized study to compare hyperfractionation and two variants of accelerated fractionation to standard fractionation radiotherapy for head and neck squamous cell carcinomas: first report of RTOG 9003. Int J Radiat Oncol Biol Phys 48:7–16PubMedCrossRef
9.
Nguyen-Tan P, Zhang E, Wheeler RH et al (2013) A phase 3 trial to test accelerated versus standrad fractionation in combination with concurrent cisplatin for head and neck carcinomas (RTOG 0129): long-term report of efficacy and toxicity. Int J Radiat Oncol Biol Phys 87:S56–S57CrossRef
10.
Pignon JP, le Maître A, Maillard E, Bourhis J, MACH-NC Collaborative Group (2009) Meta-analysis of chemotherapy in head and neck cancer (MACH-NC): an update on 93 randomised trials and 17,346 patients. Radiother Oncol 92:4–14PubMedCrossRef
Metadata
Title
„Bananenkurve“ im Überleben nach alleiniger Strahlentherapie fortgeschrittener Kopf-Hals-Karzinome
Author
Hartmut T. Klages
Publication date
01-10-2014
Publisher
Springer Berlin Heidelberg
Published in
Strahlentherapie und Onkologie / Issue 10/2014
Print ISSN: 0179-7158
Electronic ISSN: 1439-099X
DOI
https://doi.org/10.1007/s00066-014-0729-7

Other articles of this Issue 10/2014

Strahlentherapie und Onkologie 10/2014 Go to the issue

Original article

Strong adverse prognostic impact of hyperglycemic episodes during adjuvant chemoradiotherapy of glioblastoma multiforme

Original article

Inverse prognostic impact of ErbB2 mRNA and protein expression level in tumors of soft tissue sarcoma patients

Editorial

How nescience may obscure evidence

Case study

FET-PET-based reirradiation and chloroquine in patients with recurrent glioblastoma

Original article

MRI-detected skull-base invasion

Original article

Metastatic spinal cord compression